Longevity AI Leverage HLI’s growing AI foundation, lineage of large-scale genomics and partnerships with Insilico Medicine to position offerings around AI-driven longevity insights, precision health, and longevity-focused clinical decision support.

Genomics Data Target opportunities around data collaboration and analytics services by offering secure data integration, phenotype-genotype correlation, and access to HLI’s expansive whole genome database for partner research and biomarker discovery.

Strategic Partnerships Capitalize on ongoing collaborations with LEV Foundation, Alamar Biosciences and Simplify Genomics to propose joint offerings in aging research, early disease detection, and expanded proteomics or genomic testing services.

Clinical Scale Position solutions for CAP/CLIA-certified laboratory workflows, testing services, and regulatory-grade data generation to support potential customers seeking validated genomics and proteomics capabilities at scale.

Mobile Engagement Explore opportunities to expand consumer-facing health management via the new mobile platform, offering personalized risk tracking, proactive health monitoring, and engagement tools to drive actionable longevity insights.